Replies to post #9613 on The Rising Influence of Rising Affluence

[DewDiligence]

MYL just became more of a ‘TGDT’ company:

http://www.wsj.com/articles/mylan-reaches-7-2-billion-deal-for-swedens-meda-1455140159

Mylan said the deal to buy Meda will build on its portfolio of specialty generic and over-the-counter products. The acquisition will also give Mylan access to new markets like China, Russia and the Middle East.

See #msg-120456111 for related info.

[DewDiligence]

ABT has sold 77% of its original (Jan 2015) MYL holding—and now owns 25.8M shares (a 4.8% stake):

https://www.sec.gov/Archives/edgar/data/1800/000110465917018990/a17-9815_1sc13da.htm

Since ABT’s stake in MYL is now <5%, no further reports on Form 13D will need to be filed.